About Paragon 28 Inc
Ticker
info
FNA
Trading on
info
NYSE
ISIN
info
US69913P1057
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Albert DaCosta
Headquarters
info
14445 Grasslands Drive, Englewood, CO, United States, 80112
Employees
info
525
Website
info
https://paragon28.com
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix. The company serves hospitals, ambulatory surgery centers, and health care facilities through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. As of April 21, 2025, Paragon 28, Inc. operates as a subsidiary of Zimmer Biomet Holdings, Inc.
Metrics
BasicAdvanced
Market cap
info
$1.1B
P/E ratio
info
-
EPS
info
-$0.66
Dividend Yield
info
0.00%
Beta
info
1.47
Forward P/E ratio
info
0
EBIDTA
info
$-22.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.1B
Average daily volume
info
-
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
4.29
Price to book
info
8.41
Earnings
EPS
info
-$0.66
EPS estimate (current quarter)
info
-$0.10
EPS estimate (next quarter)
info
-$0.15
EBITDA
info
$-22.2M
Revenues (TTM)
info
$256M
Revenues per share (TTM)
info
$3.08
Technicals
Beta
info
1.47
52-week High
info
$13.13
52-week Low
info
$4.65
50-day moving average
info
$13.03
200-day moving average
info
$9.71
Short ratio
info
0.64
Short %
info
2.13%
Management effectiveness
ROE (TTM)
info
-36.39%
ROA (TTM)
info
-8.18%
Profit margin
info
-21.33%
Gross profit margin
info
$191M
Operating margin
info
-8.97%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
18.50%
Share stats
Outstanding Shares
info
83.9M
Float
info
44.2M
Insiders %
info
31.22%
Institutions %
info
50.84%
Analyst Insights & forecasts
info

34% Buy

66% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$15.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.18
-$0.12
-50.00%
Q1 • 24Missed
-$0.17
-$0.17
-
Q2 • 24Beat
-$0.14
-$0.16
10.19%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$62.3M
$-12.3M
-19.79%
Q3 • 24
$71.7M
$-11.1M
-15.50%
Q4 • 24
15.10%
-9.87%
-21.70%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$302M
$163M
53.83%
Q3 • 24
$291M
$160M
55.08%
Q4 • 24
-3.74%
-1.50%
2.32%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2.6M
$-3.8M
$0.1M
$-6.7M
Q3 • 24
$-3.3M
$-2.6M
$-0.4M
$-6.2M
Q4 • 24
23.88%
-32.09%
-383.46%
-7.21%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Paragon 28 Inc share?
Collapse

Paragon 28 Inc shares are currently traded for undefined per share.

How many shares does Paragon 28 Inc have?
Collapse

Paragon 28 Inc currently has 83.9M shares.

Does Paragon 28 Inc pay dividends?
Collapse

No, Paragon 28 Inc doesn't pay dividends.

What is Paragon 28 Inc 52 week high?
Collapse

Paragon 28 Inc 52 week high is $13.13.

What is Paragon 28 Inc 52 week low?
Collapse

Paragon 28 Inc 52 week low is $4.65.

What is the 200-day moving average of Paragon 28 Inc?
Collapse

Paragon 28 Inc 200-day moving average is $9.71.

Who is Paragon 28 Inc CEO?
Collapse

The CEO of Paragon 28 Inc is Albert DaCosta.

How many employees Paragon 28 Inc has?
Collapse

Paragon 28 Inc has 525 employees.

What is the market cap of Paragon 28 Inc?
Collapse

The market cap of Paragon 28 Inc is $1.1B.

What is the P/E of Paragon 28 Inc?
Collapse

The current P/E of Paragon 28 Inc is null.

What is the EPS of Paragon 28 Inc?
Collapse

The EPS of Paragon 28 Inc is -$0.66.

What is the PEG Ratio of Paragon 28 Inc?
Collapse

The PEG Ratio of Paragon 28 Inc is null.

What do analysts say about Paragon 28 Inc?
Collapse

According to the analysts Paragon 28 Inc is considered a hold.